DOCSLIB.ORG

Chapter 6 PRETREATMENT for NERVE AGENT EXPOSURE

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Chapter 6 PRETREATMENT for NERVE AGENT EXPOSURE Pretreatment for Nerve Agent Exposure Chapter 6 PRETREATMENT FOR NERVE AGENT EXPOSURE MICHAEL A. DUNN, M.D., FACP*; BRENNIE E. HACKLEY, JR., PH.D.†; AND FREDERICK R. SIDELL, M.D.‡ INTRODUCTION AGING OF NERVE AGENT–BOUND ACETYLCHOLINESTERASE PYRIDOSTIGMINE, A PERIPHERALLY ACTING CARBAMATE COMPOUND Efficacy Safety Wartime Use Improved Delivery CENTRALLY ACTING NERVE AGENT PRETREATMENTS NEW DIRECTIONS: BIOTECHNOLOGICAL PRETREATMENTS SUMMARY *Colonel, Medical Corps, U.S. Army; Director, Clinical Consultation, Office of the Assistant Secretary of Defense (Health Affairs), Washing- ton, D.C. 20301-1200; formerly, Commander, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Mary- land 21010-5425 †Scientific Advisor, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5425 ‡Formerly, Chief, Chemical Casualty Care Office, and Director, Medical Management of Chemical Casualties Course, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5425; currently, Chemical Casualty Consultant, 14 Brooks Road, Bel Air, Maryland 21014 181 Medical Aspects of Chemical and Biological Warfare INTRODUCTION Nerve agents are rapidly acting chemical com- cal as well and may impair physical and mental pounds that can cause respiratory arrest within performance. A pretreatment must be administered minutes of absorption. Their speed of action im- to an entire force under a nerve agent threat. Any poses a need for rapid and appropriate reaction by resulting performance decrement, even a compara- exposed soldiers, their buddies, or medics, who tively minor one, would make pretreatment use must administer antidotes quickly enough to save unacceptable in battlefield situations requiring lives. A medical defense against nerve agents that maximum alertness and performance for survival. depends completely on postexposure antidote treat- In the late 1980s, the United States, following the ment, however, has two key limitations: example of Great Britain, stocked the compound pyridostigmine for its combat units as a wartime • In the stress of a chemical environment, contingency pretreatment adjunct for nerve agent even well-trained military personnel will exposure.3 Several other Allies, including most not be uniformly successful in performing members of the North Atlantic Treaty Organization such tasks as self- and buddy-admin- (NATO), did so as well. At the recommended dose, istration of nerve agent antidotes.1 pyridostigmine is free of performance-limiting side • Aging, a change over time in the interac- effects. Unfortunately, pyridostigmine by itself is tion of nerve agents with the target enzyme ineffective as a pretreatment against subsequent acetylcholinesterase (AChE), renders oxime nerve agent exposure and thus it is not a true pre- therapy (an important component of nerve treatment compound. Pyridostigmine pretreatment agent antidotes) much less effective.2 As does provide greatly improved protection against explained below, aging poses an especially soman exposure, however, when combined with difficult problem for treating effects from postexposure antidote therapy. For this reason, the nerve agent soman. pyridostigmine is classified as a pretreatment adjunct. Research workers have attempted to develop true Because of these limitations of postexposure pro- nerve agent pretreatments whose own neurotoxic- tection, military physicians have focused on the ity is balanced or diminished by coadministration possibility of protecting soldiers from nerve agents of a pharmacological antagonist to their undesir- by medical prophylaxis, or pretreatment, designed able properties (eg, the carbamate compound phy- to limit the toxicity of a subsequent nerve agent ex- sostigmine, which is administered in combination posure. A significant problem with pretreatments, with a cholinolytic compound, such as scopola- however, has been their own potential for adverse mine). The potential and the problems of this pre- effects. In general, the pharmacological pretreatments treatment approach are considered in this chapter, that protect humans from the toxic effects of nerve along with a new pretreatment concept that in- agents are themselves neuroactive compounds. volves inactivating or binding nerve agents with Thus, their principal adverse actions are neurologi- scavenger macromolecules in the circulation. AGING OF NERVE AGENT–BOUND ACETYLCHOLINESTERASE Organophosphate nerve agents inhibit the active ylation of the AChE-bound nerve agent molecule pro- site of AChE, a key enzymatic regulator of cholin- ceeds depends on the nature of the nerve agent. ergic neurotransmission. As noted in Chapter 5, Table 6-1 shows the aging half-time of each of the Nerve Agents, agent-bound AChE can be reacti- five chemical compounds commonly considered to vated by a class of antidote compounds, the oximes, be nerve agents: tabun (GA), sarin (GB), soman which remove the nerve agent molecule from the (GD), GF, and VX. catalytic site of AChE. Aging is an irreversible reaction. After de- During the attachment of the agent with the en- alkylation, an AChE-bound nerve agent molecule zyme, a portion of the agent—the leaving group— can no longer be removed from the enzyme by breaks off. During a second, later reaction, one of an oxime. Thus, aging of enzyme-bound nerve the nerve agent’s alkyl groups leaves: this is the agent prevents oxime antidotes from reactivating process known as aging. The rate at which this dealk- AChE. This is an extremely difficult problem in the 182 Pretreatment for Nerve Agent Exposure TABLE 6-1 AGING HALF-TIME OF NERVE AGENTS Aging Nerve Agent RBC-ChE Source Half-Time GA (Tabun) Human (in vitro) >14 h1 Human (in vitro) 13.3 h2 RBC-ChE: erythrocyte cholinesterase 3 GB (Sarin) Human (in vivo) 5 h Data sources: (1) Mager PP. Multidimensional Pharmacochemistry. San Diego, Calif: Academic Press; 1984: 52–53. (2) Doctor BP, Human (in vitro) 3 h1 Blick DW, Caranto G, et al. Cholinesterases as scavengers for 4 organophosphorus compounds: Protection of primate perfor- GD (Soman) Marmoset (in vivo) 1.0 min mance against soman toxicity. Chem Biol Interact. 1993;87:285– Guinea pig (in vivo) 7.5 min4 293. (3) Sidell FR, Groff WA. The reactivatibility of cholinest- erase inhibited by VX and sarin in man. Toxicol Appl Pharm. Rat (in vivo) 8.6 min4 1974;27:241–252. (4) Talbot BG, Anderson DR, Harris LW, Yarbrough LW, Lennox WJ. A comparison of in vivo and in vitro 1 Human (in vitro) 2–6 min rates of aging of soman-inhibited erythrocyte acetylcholinest- erase in different animal species. Drug Chem Toxicol. 1988;11:289– GF Human (in vitro) 40 h1 305. (5) Hill DL, Thomas NC. Reactivation by 2-PAM Cl of Hu- man Red Blood Cell Cholinesterase Poisoned in vitro by Cyclohexyl- Human (in vitro) 7.5 h5 methylphosphonofluoridate (GF). Edgewood Arsenal, Md: Medi- cal Research Laboratory; 1969. Edgewood Arsenal Technical VX Human (in vivo) 48 h3 Report 43-13. case of poisoning with soman, which ages within 2 of exposure (mg•min). For example, a PR of 1.0 minutes. would indicate a completely ineffective antidote, Aging appears to be a key limiting factor in the because it means that the LD50 or LCt50 is the same efficacy of postexposure oxime therapy for soman for subjects who received an antidote and those who poisoning. One method for assessing the relative did not. A PR of 5, on the other hand, indicates that efficacy of antidotes and other countermeasures is the LD50 or LCt50 for subjects who received an an- the determination of their protective ratios. The tidote is 5-fold higher than that for subjects who protective ratio (PR) of an antidote is the factor by did not receive one. A PR of 5 or greater is consid- which it raises the LD50 or the LCt50 of a toxic nerve ered to represent a reasonable level of effectiveness agent challenge. Readers will remember that LD50 for medical countermeasures against nerve agents. is defined as the dose (D) of liquid or solid nerve This value was determined through threat analysis agent that is lethal (L) to 50% of the subjects ex- of battlefield conditions and consideration of the posed to it; LD50 is also described as the median fact that trained and equipped soldiers will be able lethal dose. LCt50 is the term used to describe the to achieve at least partial protection against nerve median lethal concentration for an aerosol or va- agent attacks by rapid donning of masks and use por agent, expressed as concentration (C) • time (t) of chemical protective clothing. PYRIDOSTIGMINE, A PERIPHERALLY ACTING CARBAMATE COMPOUND Pyridostigmine is one of a class of neuro- (CNS). Pyridostigmine has been used for many active compounds called carbamates. Its chemical years in the therapy of neurological disorders, structure and that of a related carbamate, physo- especially myasthenia gravis, a disease of neuro- stigmine, are shown below. Like the nerve agents, muscular transmission. In patients with myasthe- carbamates inhibit the enzymatic activity of AChE. nia gravis, inhibition of synaptic AChE is clinically As a quaternary amine, pyridostigmine is ionized beneficial. under normal physiological conditions and pen- As an inhibitor of AChE, pyridostigmine in large etrates poorly into the central nervous system doses mimics the peripheral toxic effects of the or- 183 Medical Aspects of Chemical and Biological Warfare H3C CH3 + N C O NCH3 H3C N C O H3C O H O NN CH3 CH3 Pyridostigmine Physostigmine ganophosphate nerve agents. At first it might seem fore
Load more

Recommended publications
  • Modifications on the Basic Skeletons of Vinblastine and Vincristine
    Molecules 2012, 17, 5893-5914; doi:10.3390/molecules17055893 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Modifications on the Basic Skeletons of Vinblastine and Vincristine Péter Keglevich, László Hazai, György Kalaus and Csaba Szántay * Department of Organic Chemistry and Technology, University of Technology and Economics, H-1111 Budapest, Szt. Gellért tér 4, Hungary * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel: +36-1-463-1195; Fax: +36-1-463-3297. Received: 30 March 2012; in revised form: 9 May 2012 / Accepted: 10 May 2012 / Published: 18 May 2012 Abstract: The synthetic investigation of biologically active natural compounds serves two main purposes: (i) the total synthesis of alkaloids and their analogues; (ii) modification of the structures for producing more selective, more effective, or less toxic derivatives. In the chemistry of dimeric Vinca alkaloids enormous efforts have been directed towards synthesizing new derivatives of the antitumor agents vinblastine and vincristine so as to obtain novel compounds with improved therapeutic properties. Keywords: antitumor therapy; vinblastine; vincristine; derivatives 1. Introduction Vinblastine (1) and vincristine (2) are dimeric alkaloids (Figure 1) isolated from the Madagaskar periwinkle plant (Catharantus roseus), exhibit significant cytotoxic activity and are used in the antitumor therapy as antineoplastic agents. In the course of cell proliferation they act as inhibitors during the metaphase of the cell cycle and by binding to the microtubules inhibit the development of the mitotic spindle. In tumor cells these agents inhibit the DNA repair and the RNA synthesis mechanisms, blocking the DNA-dependent RNA polymerase. Molecules 2012, 17 5894 Figure 1.
    [Show full text]
  • Carbamate Pesticides Aldicarb Aldicarb Sulfoxide Aldicarb Sulfone
    Connecticut General Statutes Sec 19a-29a requires the Commissioner of Public Health to annually publish a list setting forth all analytes and matrices for which certification for testing is required. Connecticut ELCP Drinking Water Analytes Revised 05/31/2018 Microbiology Total Coliforms Fecal Coliforms/ E. Coli Carbamate Pesticides Legionella Aldicarb Cryptosporidium Aldicarb Sulfoxide Giardia Aldicarb Sulfone Carbaryl Physicals Carbofuran Turbidity 3-Hydroxycarbofuran pH Methomyl Conductivity Oxamyl (Vydate) Minerals Chlorinated Herbicides Alkalinity, as CaCO3 2,4-D Bromide Dalapon Chloride Dicamba Chlorine, free residual Dinoseb Chlorine, total residual Endothall Fluoride Picloram Hardness, Calcium as Pentachlorophenol CaCO3 Hardness, Total as CaCO3 Silica Chlorinated Pesticides/PCB's Sulfate Aldrin Chlordane (Technical) Nutrients Dieldrin Endrin Ammonia Heptachlor Nitrate Heptachlor Epoxide Nitrite Lindane (gamma-BHC) o-Phosphate Metolachlor Total Phosphorus Methoxychlor PCB's (individual aroclors) Note 1 PCB's (as decachlorobiphenyl) Note 1 Demands Toxaphene TOC Nitrogen-Phosphorus Compounds Alachlor Metals Atrazine Aluminum Butachlor Antimony Diquat Arsenic Glyphosate Barium Metribuzin Beryllium Paraquat Boron Propachlor Cadmium Simazine Calcium Chromium Copper SVOC's Iron Benzo(a)pyrene Lead bis-(2-ethylhexyl)phthalate Magnesium bis-(ethylhexyl)adipate Manganese Hexachlorobenzene Mercury Hexachlorocyclopentadiene Molybdenum Nickel Potassium Miscellaneous Organics Selenium Dibromochloropropane (DBCP) Silver Ethylene Dibromide (EDB)
    [Show full text]
  • WO 2018/005077 Al O O© O
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/005077 Al 04 January 2018 (04.01.2018) W ! P O PCT (51) International Patent Classification: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, A61K 31/78 (2006.01) C08J 7/04 (2006.01) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. C08G 59/77 (2006.01) (84) Designated States (unless otherwise indicated, for every (21) International Application Number: kind of regional protection available): ARIPO (BW, GH, PCT/US20 17/037 176 GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (22) International Filing Date: TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 13 June 2017 (13.06.2017) EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, (25) Filing Language: English MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (26) Publication Language: English KM, ML, MR, NE, SN, TD, TG). (30) Priority Data: 62/356,918 30 June 2016 (30.06.2016) US Published: — with international search report (Art. 21(3)) (71) Applicant: ELEMENTIS SPECIALTIES, INC. [US/US]; 469 Old Trenton Road, East Windsor, NJ 085 12 (US). (72) Inventors: IJDO, Wouter; 1224 Bridle Estates Dri ve, Yardley, PA 19067 (US). CHEN, Yanhui; 4 Hal- stead Place, Princeton, NJ 08540 (US).
    [Show full text]
  • Nerve Agent - Lntellipedia Page 1 Of9 Doc ID : 6637155 (U) Nerve Agent
    This document is made available through the declassification efforts and research of John Greenewald, Jr., creator of: The Black Vault The Black Vault is the largest online Freedom of Information Act (FOIA) document clearinghouse in the world. The research efforts here are responsible for the declassification of MILLIONS of pages released by the U.S. Government & Military. Discover the Truth at: http://www.theblackvault.com Nerve Agent - lntellipedia Page 1 of9 Doc ID : 6637155 (U) Nerve Agent UNCLASSIFIED From lntellipedia Nerve Agents (also known as nerve gases, though these chemicals are liquid at room temperature) are a class of phosphorus-containing organic chemicals (organophosphates) that disrupt the mechanism by which nerves transfer messages to organs. The disruption is caused by blocking acetylcholinesterase, an enzyme that normally relaxes the activity of acetylcholine, a neurotransmitter. ...--------- --- -·---- - --- -·-- --- --- Contents • 1 Overview • 2 Biological Effects • 2.1 Mechanism of Action • 2.2 Antidotes • 3 Classes • 3.1 G-Series • 3.2 V-Series • 3.3 Novichok Agents • 3.4 Insecticides • 4 History • 4.1 The Discovery ofNerve Agents • 4.2 The Nazi Mass Production ofTabun • 4.3 Nerve Agents in Nazi Germany • 4.4 The Secret Gets Out • 4.5 Since World War II • 4.6 Ocean Disposal of Chemical Weapons • 5 Popular Culture • 6 References and External Links --------------- ----·-- - Overview As chemical weapons, they are classified as weapons of mass destruction by the United Nations according to UN Resolution 687, and their production and stockpiling was outlawed by the Chemical Weapons Convention of 1993; the Chemical Weapons Convention officially took effect on April 291997. Poisoning by a nerve agent leads to contraction of pupils, profuse salivation, convulsions, involuntary urination and defecation, and eventual death by asphyxiation as control is lost over respiratory muscles.
    [Show full text]
  • Warning: the Following Lecture Contains Graphic Images
    What the новичок (Novichok)? Why Chemical Warfare Agents Are More Relevant Than Ever Matt Sztajnkrycer, MD PHD Professor of Emergency Medicine, Mayo Clinic Medical Toxicologist, Minnesota Poison Control System Medical Director, RFD Chemical Assessment Team @NoobieMatt #ITLS2018 Disclosures In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards, the American Nurses Credentialing Center’s Commission (ANCC) and the Commission on Accreditation for Pre-Hospital Continuing Education (CAPCE), states presenters must disclose the existence of significant financial interests in or relationships with manufacturers or commercial products that may have a direct interest in the subject matter of the presentation, and relationships with the commercial supporter of this CME activity. The presenter does not consider that it will influence their presentation. Dr. Sztajnkrycer does not have a significant financial relationship to report. Dr. Sztajnkrycer is on the Editorial Board of International Trauma Life Support. Specific CW Agents Classes of Chemical Agents: The Big 5 The “A” List Pulmonary Agents Phosgene Oxime, Chlorine Vesicants Mustard, Phosgene Blood Agents CN Nerve Agents G, V, Novel, T Incapacitating Agents Thinking Outside the Box - An Abbreviated List Ammonia Fluorine Chlorine Acrylonitrile Hydrogen Sulfide Phosphine Methyl Isocyanate Dibotane Hydrogen Selenide Allyl Alcohol Sulfur Dioxide TDI Acrolein Nitric Acid Arsine Hydrazine Compound 1080/1081 Nitrogen Dioxide Tetramine (TETS) Ethylene Oxide Chlorine Leaks Phosphine Chlorine Common Toxic Industrial Chemical (“TIC”). Why use it in war/terror? Chlorine Density of 3.21 g/L. Heavier than air (1.28 g/L) sinks. Concentrates in low-lying areas. Like basements and underground bunkers. Reacts with water: Hypochlorous acid (HClO) Hydrochloric acid (HCl).
    [Show full text]
  • Organic & Biomolecular Chemistry
    Organic & Biomolecular Chemistry Accepted Manuscript This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. www.rsc.org/obc Page 1 of 7 Organic & Biomolecular Chemistry Journal Name RSCPublishing ARTICLE Selective chromo-fluorogenic detection of DFP (a Sarin and Soman mimic) and DCNP (a Tabun mimic) Cite this: DOI: 10.1039/x0xx00000x with a unique probe based on a boron dipyrromethene (BODIPY) dye Manuscript Received 00th January 2012, Accepted 00th January 2012 Andrea Barba-Bon,a,b Ana M. Costero,a,b* Salvador Gil,a,b Ramón Martínez- a,c,d a,c,d DOI: 10.1039/x0xx00000x Máñez, * and Félix Sancenón www.rsc.org/ A novel colorimetric probe (P4) for the selective differential detection of DFP (a Sarin and Soman mimic) and DCNP (a Tabun mimic) was prepared.
    [Show full text]
  • Medical Aspects of Chemical Warfare
    Medical Diagnostics Chapter 22 MEDICAL DIAGNOSTICS † ‡ § BENEDICT R. CAPACIO, PHD*; J. RICHARD SMITH ; RICHARD K. GORDON, PHD ; JULIAN R. HAIGH, PHD ; JOHN ¥ ¶ R. BARR, PHD ; AND GENNADY E. PLATOFF JR, PHD INTRODUCTION NERVE AGENTS SULFUR MUSTARD LEWISITE CYANIDE PHOSGENE 3-QUINUCLIDINYL BENZILATE SAMPLE CONSIDERATIONS Summary * Chief, Medical Diagnostic and Chemical Branch, Analytical Toxicology Division, US Army Medical Research Institute of Chemical Defense, 3100 Rickets Point Road, Aberdeen Proving Ground, Maryland 21010-5400 † Chemist, Medical Diagnostic and Chemical Branch, Analytical Toxicology Division, US Army Medical Research Institute of Chemical Defense, 3100 Rickets Point Road, Aberdeen Proving Ground, Maryland 21010-5400 ‡ Chief, Department of Biochemical Pharmacology, Biochemistry Division, Walter Reed Army Institute of Research, 503 Robert Grant Road, Silver Spring, Maryland 20910-7500 § Research Scientist, Department of Biochemical Pharmacology, Biochemistry Division, Walter Reed Army Institute of Research, 503 Robert Grant Road, Silver Spring, Maryland 20910-7500 ¥ Lead Research Chemist, Centers for Disease Control and Prevention, 4770 Buford Highway, Mailstop F47, Atlanta, Georgia 30341 ¶ Colonel, US Army (Retired); Scientific Advisor, Office of Biodefense Research, National Institute of Allergies and Infectious Disease, National Institutes of Health, 6610 Rockledge Drive, Room 4069, Bethesda, Maryland 20892-6612 691 Medical Aspects of Chemical Warfare INTRODUCTION In the past, issues associated with chemical war- an
    [Show full text]
  • N-Methyl Carbamate Cumulative Risk Assessment: Pilot Cumulative Analysis
    UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 OFFICE OF PREVENTION, PESTICIDES, AND TOXIC SUBSTANCES April 15, 2005 MEMORANDUM SUBJECT: Transmittal of Meeting Minutes of the FIFRA Scientific Advisory Panel Meeting Held February 15 - 18, 2005 on the N-methyl Carbamate Cumulative Risk Assessment: Pilot Cumulative Analysis TO: James J. Jones, Director Office of Pesticide Programs FROM: Myrta R. Christian, Designated Federal Official Joseph E. Bailey, Designated Federal Official FIFRA Scientific Advisory Panel Office of Science Coordination and Policy THRU: Larry C. Dorsey, Executive Secretary FIFRA Scientific Advisory Panel Office of Science Coordination and Policy Clifford J. Gabriel, Director Office of Science Coordination and Policy Attached, please find the meeting minutes of the FIFRA Scientific Advisory Panel open meeting held in Arlington, Virginia on February 15 - 18, 2005. This report addresses a set of scientific issues being considered by the Environmental Protection Agency pertaining to the N- methyl carbamate cumulative risk assessment: pilot cumulative analysis. Attachment 1 of 113 cc: Susan Hazen Margaret Schneider Anne Lindsay Margie Fehrenbach Janet Andersen Debbie Edwards Steven Bradbury William Diamond Arnold Layne Tina Levine Lois Rossi Frank Sanders Richard Keigwin Randolph Perfetti William Jordan Douglas Parsons Enesta Jones Vanessa Vu (SAB) Anna Lowit David J. Miller Nelson Thurman Dirk Young David Hrdy Jeff Evans Steve Nako Stephanie Padilla R. Woodrow Setzer Ginger Moser Miles Okino Jerry Blancato Fred Power Curtis Dary Tom Nolan, USGS OPP Docket 2 of 113 FIFRA Scientific Advisory Panel Members Stephen M. Roberts, Ph.D. (Chair of the FIFRA SAP) Janice E. Chambers, Ph.D. H. Christopher Frey, Ph.D.
    [Show full text]
  • 744 Hydrolysis of Chiral Organophosphorus Compounds By
    [Frontiers in Bioscience, Landmark, 26, 744-770, Jan 1, 2021] Hydrolysis of chiral organophosphorus compounds by phosphotriesterases and mammalian paraoxonase-1 Antonio Monroy-Noyola1, Damianys Almenares-Lopez2, Eugenio Vilanova Gisbert3 1Laboratorio de Neuroproteccion, Facultad de Farmacia, Universidad Autonoma del Estado de Morelos, Morelos, Mexico, 2Division de Ciencias Basicas e Ingenierias, Universidad Popular de la Chontalpa, H. Cardenas, Tabasco, Mexico, 3Instituto de Bioingenieria, Universidad Miguel Hernandez, Elche, Alicante, Spain TABLE OF CONTENTS 1. Abstract 2. Introduction 2.1. Organophosphorus compounds (OPs) and their toxicity 2.2. Metabolism and treatment of OP intoxication 2.3. Chiral OPs 3. Stereoselective hydrolysis 3.1. Stereoselective hydrolysis determines the toxicity of chiral compounds 3.2. Hydrolysis of nerve agents by PTEs 3.2.1. Hydrolysis of V-type agents 3.3. PON1, a protein restricted in its ability to hydrolyze chiral OPs 3.4. Toxicity and stereoselective hydrolysis of OPs in animal tissues 3.4.1. The calcium-dependent stereoselective activity of OPs associated with PON1 3.4.2. Stereoselective hydrolysis commercial OPs pesticides by alloforms of PON1 Q192R 3.4.3. PON1, an enzyme that stereoselectively hydrolyzes OP nerve agents 3.4.4. PON1 recombinants and stereoselective hydrolysis of OP nerve agents 3.5. The activity of PTEs in birds 4. Conclusions 5. Acknowledgments 6. References 1. ABSTRACT Some organophosphorus compounds interaction of the racemic OPs with these B- (OPs), which are used in the manufacturing of esterases (AChE and NTE) and such interactions insecticides and nerve agents, are racemic mixtures have been studied in vivo, ex vivo and in vitro, using with at least one chiral center with a phosphorus stereoselective hydrolysis by A-esterases or atom.
    [Show full text]
  • Professor Jo Klaveness School of Pharmacy University of Oslo
    SUPERVISORS Professor Jo Klaveness School of Pharmacy University of Oslo Associate professor Pål Rongved School of Pharmacy University of Oslo 1 TABLE OF CONTENTS TABLE OF CONTENTS 1 ABBREVIATIONS..........................................................................5 2 ABSTRACT.....................................................................................6 3 INTRODUCTION............................................................................7 3.1 Acetylcholine- a neurotransmitter Synthesis, release and inactivation ... 7 3.1.1 Structure of acetylcholinesterase .................................................................... 8 3.2 Anticholinesterases interfere with acetylcholine activity ........................ 9 3.3 Effects of anticholinesterases................................................................... 9 3.4 Different groups of anticholinesterases.................................................. 10 3.4.1 Short- acting anticholinesterases .................................................................. 10 3.4.2 Medium- duration anticholinesterases .......................................................... 11 3.4.3 Irreversible anticholinesterases..................................................................... 12 3.5 Nerve agents: Irreversible anticholinesterases....................................... 13 3.5.1 The dawn of a deadly weapon ...................................................................... 14 3.5.2 Biochemistry................................................................................................
    [Show full text]
  • Enzymatic Degradation of Organophosphorus Pesticides and Nerve Agents by EC: 3.1.8.2
    catalysts Review Enzymatic Degradation of Organophosphorus Pesticides and Nerve Agents by EC: 3.1.8.2 Marek Matula 1, Tomas Kucera 1 , Ondrej Soukup 1,2 and Jaroslav Pejchal 1,* 1 Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; [email protected] (M.M.); [email protected] (T.K.); [email protected] (O.S.) 2 Biomedical Research Center, University Hospital Hradec Kralove, Sokolovska 581, 500 05 Hradec Kralove, Czech Republic * Correspondence: [email protected] Received: 26 October 2020; Accepted: 20 November 2020; Published: 24 November 2020 Abstract: The organophosphorus substances, including pesticides and nerve agents (NAs), represent highly toxic compounds. Standard decontamination procedures place a heavy burden on the environment. Given their continued utilization or existence, considerable efforts are being made to develop environmentally friendly methods of decontamination and medical countermeasures against their intoxication. Enzymes can offer both environmental and medical applications. One of the most promising enzymes cleaving organophosphorus compounds is the enzyme with enzyme commission number (EC): 3.1.8.2, called diisopropyl fluorophosphatase (DFPase) or organophosphorus acid anhydrolase from Loligo Vulgaris or Alteromonas sp. JD6.5, respectively. Structure, mechanisms of action and substrate profiles are described for both enzymes. Wild-type (WT) enzymes have a catalytic activity against organophosphorus compounds, including G-type nerve agents. Their stereochemical preference aims their activity towards less toxic enantiomers of the chiral phosphorus center found in most chemical warfare agents. Site-direct mutagenesis has systematically improved the active site of the enzyme. These efforts have resulted in the improvement of catalytic activity and have led to the identification of variants that are more effective at detoxifying both G-type and V-type nerve agents.
    [Show full text]
  • Selective Effects of Carbamate Pesticides on Rat Neuronal Nicotinic Acetylcholine Receptors and Rat Brain Acetylcholinesterase Chantal J.G.M
    Available online at www.sciencedirect.com R Toxicology and Applied Pharmacology 193 (2003) 139–146 www.elsevier.com/locate/taap Selective effects of carbamate pesticides on rat neuronal nicotinic acetylcholine receptors and rat brain acetylcholinesterase Chantal J.G.M. Smulders,a Tjerk J.H. Bueters,b Regina G.D.M. Van Kleef,a and Henk P.M. Vijverberga,* a Institute for Risk Assessment Sciences, Utrecht University, P.O. Box 80176, NL-3508 TD Utrecht, The Netherlands b TNO Prins Maurits Laboratory, P.O. Box 45, NL-2280 AA Rijswijk, The Netherlands Received 14 May 2003; accepted 31 July 2003 Abstract Effects of commonly used carbamate pesticides on rat neuronal nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes have been investigated using the two-electrode voltage clamp technique. The potencies of these effects have been compared to the potencies of the carbamates to inhibit rat brain acetylcholinesterase. The potency order of six carbamates to inhibit ␣4␤4 nicotinic receptors is fenoxycarb Ͼ EPTC Ͼ carbaryl, bendiocarb Ͼ propoxur Ͼ aldicarb with IC50 values ranging from 3 ␮M for fenoxycarb to 165 ␮M for propoxur and Ͼ1 mM for aldicarb. Conversely, the potency order of these carbamates to inhibit rat brain acetylcholinesterase is bendiocarb Ͼ propoxur, aldicarb Ͼ carbaryl ϾϾ EPTC, fenoxycarb with IC50 values ranging from 1 ␮M for bendiocarb to 17 ␮M for carbaryl and ϾϾ1 mM for EPTC and fenoxycarb. The ␣4␤2, ␣3␤4, and ␣3␤2 nicotinic acetylcholine receptors are inhibited by fenoxycarb, EPTC, and carbaryl with potency orders similar to that for ␣4␤4 receptors. Comparing the potencies of inhibition of the distinct subtypes of nicotinic acetylcholine receptors shows that the ␣3␤2 receptor is less sensitive to inhibition by fenoxycarb and EPTC.
    [Show full text]